P000013S014

None

FDA Premarket Approval P000013 S014

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP000013S014
Classification NameNone
Applicant
PMAP000013
SupplementS014

Supplemental Filings

Supplement NumberDateSupplement Type
P000013Original Filing
S020 2022-03-03 Special (immediate Track)
S019 2022-02-03 30-day Notice
S018 2021-01-05 Real-time Process
S017 2020-07-06 Real-time Process
S016 2018-11-26 30-day Notice
S015 2018-09-20 30-day Notice
S014
S013 2016-02-04 30-day Notice
S012 2015-10-01 30-day Notice
S011 2011-11-10 Normal 180 Day Track No User Fee
S010 2011-10-03 Real-time Process
S009 2009-04-16 Special (immediate Track)
S008 2006-12-29 Real-time Process
S007
S006 2006-02-22 30-day Notice
S005 2004-09-09 Real-time Process
S004 2004-04-15 Real-time Process
S003 2003-08-13 Normal 180 Day Track No User Fee
S002 2003-06-12 Real-time Process
S001 2003-02-04 Real-time Process

NIH GUDID Devices

Device IDPMASupp
04546540516879 P000013 001
04546540516862 P000013 001
04546540516855 P000013 001
04546540516848 P000013 001
04546540516831 P000013 001
04546540259936 P000013 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.